PUBBLICAZIONI GISCAD

pagina 10

· 

Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 

5-fluorouracil and leucovorin: a GISCAD study

Zaniboni A, Labianca R, Martignoni G, Barni S, Vinci M, Vaghi M, Pirovano M, Facendola G, Marini G, Luporini G.

J Chemother 1996; Feb 8 (1): 82-4

· 

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer

International Multicentre Pooled Analysis of Colon Cancer Trial. (IMPACT investigators).

Lancet, 1995; 345: 939-44

· 

Epirubicin, cisplatin and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. 

An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report

Zaniboni A, Barni S, Labianca R, Marini G, Pancera G, Giaccon G, Piazza E, Signaroldi A, Legnani W, Luporini G.

Cancer 1995; Nov 15; 76(10): 1694-9

· 

Oral etoposide as second-line chemotherapy for colorectal cancer: a GISCAD study. Gruppo Italiano Studio Carcinomi Apparato Digerente

Zaniboni A, Labianca R, Pancera G, Barni S, Frontini L,  Marini G, Luporini G.

J Chemother 1995; Jul 7(3): 246-08

· 

Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid.

The GIDCAD experience

Labianca R, Giaccon G, Barni S, Ambrosini G, Irillo A, Fiorentini G, Duro M, Piazza E, Oliani C, Pancera G, Cascinu S, Martignoni G, Zaniboni A, Dallavalle G, Luporini G and Italian Group for the Study of Digestive Tract Cancer

Eur J Cancer 1994; 30A (11): 1611-6

· 

Preliminary report of an ongoing trial comparing surgery alone versus surgery and chemotherapy in operable gastric cancer.

Di Costanzo F, Gasperoni S, Labianca R, Sdrobolini A, Zamparelli G, Angiona S, Bartolucci R, Rossetti R.

J Chemother, 1996; 8 (suppl 4): 104-06

Biochimica modulation of fluoropyrimidines: the GISCAD studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)

· 

Adv Exp Med Boil 1993; 339: 233-7

Labianca R, Pancera G, Barni S, Cascinu S, Comella G, Foa P, Martignoni G, Zaniboni A, Giaccon G, Luporini G.

Folinic acid + 5-fluorouracil (5-FU) versus equipoise 5-FU in advanced colorectal cancer. Phase III study of "GISCAD" (Italian Group for the Study of Digestive Tract Cancer)

· 

Labianca R, Pancera G, Aitini E, Barni S, Beretta A, Beretta GD, Cesana B, Comella G, Cozzaglio L, Cristoni M, Spagnoli P, Frontini L, Gottardi O, Martignoni G, Scapaticci R, Smerieri F, Vinci M, Ladro A, Zaniboni A, Luporini G.

Ann Oncol. 1991, Oct 2 (9): 673-9

FONDAZIONE
GISCAD

GRUPPO ITALIANO PER LO STUDIO DEI 

CARCINOMI DELL'APPARATO DIGERENTE

SEDE

Via Gattinoni, 4

20043 Vanzago (MI)

CONTATTI

Tel. 02 84968409

ufficio.operativo@giscad.it

© 2018 Fondazione GISCAD - P.IVA 05396970963